219 related articles for article (PubMed ID: 33560381)
1. Restoring RUNX1 deficiency in RUNX1 familial platelet disorder by inhibiting its degradation.
Krutein MC; Hart MR; Anderson DJ; Jeffery J; Kotini AG; Dai J; Chien S; DelPriore M; Borst S; Maguire JA; French DL; Gadue P; Papapetrou EP; Keel SB; Becker PS; Horwitz MS
Blood Adv; 2021 Feb; 5(3):687-699. PubMed ID: 33560381
[TBL] [Abstract][Full Text] [Related]
2. Targeted correction of RUNX1 mutation in FPD patient-specific induced pluripotent stem cells rescues megakaryopoietic defects.
Connelly JP; Kwon EM; Gao Y; Trivedi NS; Elkahloun AG; Horwitz MS; Cheng L; Liu PP
Blood; 2014 Sep; 124(12):1926-30. PubMed ID: 25114263
[TBL] [Abstract][Full Text] [Related]
3. Haematological spectrum and genotype-phenotype correlations in nine unrelated families with RUNX1 mutations from the French network on inherited platelet disorders.
Latger-Cannard V; Philippe C; Bouquet A; Baccini V; Alessi MC; Ankri A; Bauters A; Bayart S; Cornillet-Lefebvre P; Daliphard S; Mozziconacci MJ; Renneville A; Ballerini P; Leverger G; Sobol H; Jonveaux P; Preudhomme C; Nurden P; Lecompte T; Favier R
Orphanet J Rare Dis; 2016 Apr; 11():49. PubMed ID: 27112265
[TBL] [Abstract][Full Text] [Related]
4. RUNX1 deficiency (familial platelet disorder with predisposition to myeloid leukemia, FPDMM).
Schlegelberger B; Heller PG
Semin Hematol; 2017 Apr; 54(2):75-80. PubMed ID: 28637620
[TBL] [Abstract][Full Text] [Related]
5. [Familial platelet disorder with predisposition to myeloid leukemia (FPD/AML): a case report and literature review].
Zhang RR; Chen XJ; Ren YY; Yang WY; Zhu XF
Zhonghua Xue Ye Xue Za Zhi; 2021 Apr; 42(4):308-312. PubMed ID: 33979975
[No Abstract] [Full Text] [Related]
6. Targeted gene correction of RUNX1 in induced pluripotent stem cells derived from familial platelet disorder with propensity to myeloid malignancy restores normal megakaryopoiesis.
Iizuka H; Kagoya Y; Kataoka K; Yoshimi A; Miyauchi M; Taoka K; Kumano K; Yamamoto T; Hotta A; Arai S; Kurokawa M
Exp Hematol; 2015 Oct; 43(10):849-57. PubMed ID: 26021490
[TBL] [Abstract][Full Text] [Related]
7. Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients.
Sakurai M; Kunimoto H; Watanabe N; Fukuchi Y; Yuasa S; Yamazaki S; Nishimura T; Sadahira K; Fukuda K; Okano H; Nakauchi H; Morita Y; Matsumura I; Kudo K; Ito E; Ebihara Y; Tsuji K; Harada Y; Harada H; Okamoto S; Nakajima H
Leukemia; 2014 Dec; 28(12):2344-54. PubMed ID: 24732596
[TBL] [Abstract][Full Text] [Related]
8. Myeloid neoplasms with germ line RUNX1 mutation.
Hayashi Y; Harada Y; Huang G; Harada H
Int J Hematol; 2017 Aug; 106(2):183-188. PubMed ID: 28534116
[TBL] [Abstract][Full Text] [Related]
9. RUNX1, but not its familial platelet disorder mutants, synergistically activates PF4 gene expression in combination with ETS family proteins.
Okada Y; Watanabe M; Nakai T; Kamikawa Y; Shimizu M; Fukuhara Y; Yonekura M; Matsuura E; Hoshika Y; Nagai R; Aird WC; Doi T
J Thromb Haemost; 2013 Sep; 11(9):1742-50. PubMed ID: 23848403
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms underlying platelet function defect in a pedigree with familial platelet disorder with a predisposition to acute myelogenous leukemia: potential role for candidate RUNX1 targets.
Glembotsky AC; Bluteau D; Espasandin YR; Goette NP; Marta RF; Marin Oyarzun CP; Korin L; Lev PR; Laguens RP; Molinas FC; Raslova H; Heller PG
J Thromb Haemost; 2014 May; 12(5):761-72. PubMed ID: 24606315
[TBL] [Abstract][Full Text] [Related]
11. Bone Marrow Morphology Associated With Germline
Chisholm KM; Denton C; Keel S; Geddis AE; Xu M; Appel BE; Cantor AB; Fleming MD; Shimamura A
Pediatr Dev Pathol; 2019; 22(4):315-328. PubMed ID: 30600763
[TBL] [Abstract][Full Text] [Related]
12. High frequency of RUNX1 biallelic alteration in acute myeloid leukemia secondary to familial platelet disorder.
Preudhomme C; Renneville A; Bourdon V; Philippe N; Roche-Lestienne C; Boissel N; Dhedin N; André JM; Cornillet-Lefebvre P; Baruchel A; Mozziconacci MJ; Sobol H
Blood; 2009 May; 113(22):5583-7. PubMed ID: 19357396
[TBL] [Abstract][Full Text] [Related]
13. In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis.
Michaud J; Wu F; Osato M; Cottles GM; Yanagida M; Asou N; Shigesada K; Ito Y; Benson KF; Raskind WH; Rossier C; Antonarakis SE; Israels S; McNicol A; Weiss H; Horwitz M; Scott HS
Blood; 2002 Feb; 99(4):1364-72. PubMed ID: 11830488
[TBL] [Abstract][Full Text] [Related]
14. [A new form of familial platelet disorder caused by germline mutations in RUNX1 in a pedigree].
Guan J; Wang LL; Wang CY; Zhu XM; Shuai HZ; Yi X; Zou L; Yu D; Cheng H
Zhonghua Nei Ke Za Zhi; 2023 Apr; 62(4):393-400. PubMed ID: 37032134
[No Abstract] [Full Text] [Related]
15. Unrelated hematopoietic stem cell transplantation for familial platelet disorder/acute myeloid leukemia with germline RUNX1 mutations.
Toratani K; Watanabe M; Kanda J; Oka T; Hyuga M; Arai Y; Iwasaki M; Sakurada M; Nannya Y; Ogawa S; Yamada T; Takaori-Kondo A
Int J Hematol; 2023 Sep; 118(3):400-405. PubMed ID: 36897502
[TBL] [Abstract][Full Text] [Related]
16. Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy.
Owen CJ; Toze CL; Koochin A; Forrest DL; Smith CA; Stevens JM; Jackson SC; Poon MC; Sinclair GD; Leber B; Johnson PR; Macheta A; Yin JA; Barnett MJ; Lister TA; Fitzgibbon J
Blood; 2008 Dec; 112(12):4639-45. PubMed ID: 18723428
[TBL] [Abstract][Full Text] [Related]
17. Gene of the issue: RUNX1 mutations and inherited bleeding.
Morgan NV; Daly ME
Platelets; 2017 Mar; 28(2):208-210. PubMed ID: 28277065
[No Abstract] [Full Text] [Related]
18. Downregulation of TREM-like transcript-1 and collagen receptor α2 subunit, two novel RUNX1-targets, contributes to platelet dysfunction in familial platelet disorder with predisposition to acute myelogenous leukemia.
Glembotsky AC; Sliwa D; Bluteau D; Balayn N; Marin Oyarzún CP; Raimbault A; Bordas M; Droin N; Pirozhkova I; Washington V; Goette NP; Marta RF; Favier R; Raslova H; Heller PG
Haematologica; 2019 Jun; 104(6):1244-1255. PubMed ID: 30545930
[TBL] [Abstract][Full Text] [Related]
19. Spectrum of clinical and genetic features of patients with inherited platelet disorder with suspected predisposition to hematological malignancies: a nationwide survey in Japan.
Yoshimi A; Toya T; Nannya Y; Takaoka K; Kirito K; Ito E; Nakajima H; Hayashi Y; Takahashi T; Moriya-Saito A; Suzuki K; Harada H; Komatsu N; Usuki K; Ichikawa M; Kurokawa M
Ann Oncol; 2016 May; 27(5):887-95. PubMed ID: 26884589
[TBL] [Abstract][Full Text] [Related]
20. CBL mutation in chronic myelomonocytic leukemia secondary to familial platelet disorder with propensity to develop acute myeloid leukemia (FPD/AML).
Shiba N; Hasegawa D; Park MJ; Murata C; Sato-Otsubo A; Ogawa C; Manabe A; Arakawa H; Ogawa S; Hayashi Y
Blood; 2012 Mar; 119(11):2612-4. PubMed ID: 22138511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]